Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Metacycline hydrochloride
and orally bioavailable inhibitors of the mammalian target of rapamycin kinase domain exhibiting single agent antiproliferative activity
Xanomeline s a muscarinic acetylcholine receptor agonist with reasonable selectivity for the M1 and M4 subtypes
Treatment of wild-type NK cells with a newly developed small molecule TAM kinase inhibitor conferred therapeutic potential
20)21/h2-3
Oprozomib iramate Metacycline hydrochlorideOprozomibm, also known as ONX 0912 and PR 047 , is a n orally bioavailable proteasome inhibitor with potential antineoplastic activity. ONX 0912 inhibits the activity of the proteasome, thereby blocking the targeted proteolysis normally performed by the proteasome; this may result in an accumulation of unwanted or misfolded proteins. Disruption of various cell signaling pathways may follow, eventually leading to the induction of apoptosis and